Overview
Charleston Oncology specializes in diagnosing and treating cancer and blood disorders across South Carolina’s Lowcountry, using a team of twelve subspecialized physicians who pair each patient with an expert in their cancer type. Care is coordinated across medical oncology, hematology, radiation oncology, surgery, and imaging through a single electronic medical record within the Roper St. Francis Healthcare network. It stands out as Charleston’s largest group of oncology specialists, formed by a 2020 merger, with access to bone marrow transplant, QOPI-certified care, clinical trials, and a broad patient-support network. Its goal is to provide personalized, high-quality cancer and blood disorder care by connecting patients with specialists and offering the latest treatments along with coordinated community-based support.
Work here?Claim your company
Simplify's Take
What believers are saying
- Roper reopened downtown Charleston Oncology at Roper Hospital in October 2023, easing congestion.
- March 2026 CAR T-cell therapy at Roper expands advanced hematologic treatment locally.
- Updated 2026 physician pages show deep specialist bench across Charleston, Summerville, Mt. Pleasant, and Walterboro.
What critics are saying
- MUSC launched a $1 billion cancer hospital plan in April 2026, targeting 2030.
- Roper's $1.2 billion North Charleston hospital, opening mid-2029, will reshape referral flows.
- Rising health-system consolidation around MUSC and Trident squeezes independent oncologists and raises recruiting costs.
What makes Charleston Oncology unique
- Roper partnership gives Charleston Oncology shared EMR, coordinated care, and six Lowcountry sites.
- QOPI certification and CMS care-model participation signal disciplined, standardized oncology operations.
- Only three South Carolina bone marrow transplant programs strengthen its blood-cancer referral moat.
Help us improve and share your feedback! Did you find this helpful?